Steven Edmundowicz
Concepts (476)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cholangiopancreatography, Endoscopic Retrograde | 39 | 2025 | 212 | 3.970 |
Why?
| | Endoscopy, Gastrointestinal | 29 | 2023 | 232 | 3.610 |
Why?
| | Endosonography | 30 | 2024 | 153 | 2.080 |
Why?
| | Bariatric Surgery | 12 | 2019 | 218 | 1.810 |
Why?
| | Endoscopy, Digestive System | 16 | 2021 | 135 | 1.720 |
Why?
| | Esophageal Neoplasms | 13 | 2022 | 333 | 1.700 |
Why?
| | Pancreatic Neoplasms | 20 | 2023 | 882 | 1.590 |
Why?
| | Endoscopy | 13 | 2020 | 322 | 1.450 |
Why?
| | Adenoma | 12 | 2023 | 220 | 1.450 |
Why?
| | Pancreatitis | 14 | 2025 | 136 | 1.370 |
Why?
| | Weight Loss | 11 | 2019 | 789 | 1.340 |
Why?
| | Gastric Balloon | 6 | 2018 | 17 | 1.330 |
Why?
| | Obesity | 17 | 2019 | 3004 | 1.300 |
Why?
| | Stents | 20 | 2025 | 529 | 1.270 |
Why?
| | Gastroplasty | 5 | 2019 | 32 | 1.250 |
Why?
| | Adenocarcinoma | 13 | 2023 | 892 | 1.110 |
Why?
| | Gastrointestinal Hemorrhage | 4 | 2019 | 134 | 1.110 |
Why?
| | Barrett Esophagus | 10 | 2022 | 158 | 1.060 |
Why?
| | Pancreatic Ducts | 11 | 2024 | 79 | 1.020 |
Why?
| | Endoscopic Ultrasound-Guided Fine Needle Aspiration | 9 | 2019 | 56 | 1.010 |
Why?
| | Colonic Neoplasms | 6 | 2015 | 246 | 1.010 |
Why?
| | Stomach Neoplasms | 5 | 2020 | 118 | 0.990 |
Why?
| | Drainage | 12 | 2024 | 174 | 0.980 |
Why?
| | Gastroenterology | 10 | 2019 | 182 | 0.920 |
Why?
| | Colonic Polyps | 7 | 2015 | 82 | 0.910 |
Why?
| | Colonoscopy | 12 | 2023 | 250 | 0.900 |
Why?
| | Gastroesophageal Reflux | 11 | 2020 | 242 | 0.850 |
Why?
| | Bile Duct Neoplasms | 4 | 2020 | 114 | 0.780 |
Why?
| | Cholestasis | 3 | 2020 | 207 | 0.720 |
Why?
| | Gastrointestinal Diseases | 4 | 2022 | 207 | 0.700 |
Why?
| | Duodenoscopes | 2 | 2020 | 7 | 0.670 |
Why?
| | Duodenum | 4 | 2019 | 74 | 0.670 |
Why?
| | Pancreatitis, Chronic | 5 | 2024 | 61 | 0.660 |
Why?
| | Esophagus | 8 | 2019 | 257 | 0.650 |
Why?
| | Pancreatic Pseudocyst | 5 | 2024 | 17 | 0.630 |
Why?
| | Pancreatic Diseases | 6 | 2023 | 67 | 0.630 |
Why?
| | Obesity, Morbid | 7 | 2019 | 273 | 0.620 |
Why?
| | Humans | 161 | 2025 | 141187 | 0.620 |
Why?
| | Middle Aged | 93 | 2025 | 34434 | 0.620 |
Why?
| | Biliary Tract Neoplasms | 1 | 2019 | 31 | 0.620 |
Why?
| | Biopsy, Fine-Needle | 8 | 2017 | 70 | 0.610 |
Why?
| | Indomethacin | 4 | 2025 | 87 | 0.610 |
Why?
| | Catheterization | 9 | 2024 | 182 | 0.600 |
Why?
| | Aged | 72 | 2025 | 24574 | 0.570 |
Why?
| | Clinical Competence | 11 | 2020 | 1202 | 0.560 |
Why?
| | Learning Curve | 6 | 2019 | 70 | 0.540 |
Why?
| | Cross Infection | 1 | 2020 | 254 | 0.530 |
Why?
| | Endoscopic Mucosal Resection | 5 | 2022 | 27 | 0.530 |
Why?
| | Radiation Exposure | 1 | 2017 | 55 | 0.530 |
Why?
| | Gastrostomy | 5 | 2019 | 122 | 0.520 |
Why?
| | Intestine, Small | 2 | 2020 | 156 | 0.520 |
Why?
| | Colonic Diseases | 3 | 2013 | 36 | 0.510 |
Why?
| | Prospective Studies | 36 | 2024 | 7739 | 0.510 |
Why?
| | Radiation Injuries | 1 | 2017 | 149 | 0.500 |
Why?
| | Jejunum | 2 | 2015 | 32 | 0.500 |
Why?
| | Treatment Outcome | 36 | 2025 | 11120 | 0.480 |
Why?
| | Self Expandable Metallic Stents | 3 | 2022 | 16 | 0.470 |
Why?
| | Smell | 1 | 2016 | 128 | 0.470 |
Why?
| | Pathology, Clinical | 1 | 2015 | 29 | 0.460 |
Why?
| | Male | 94 | 2025 | 69783 | 0.460 |
Why?
| | Cholelithiasis | 8 | 2010 | 37 | 0.460 |
Why?
| | Gastrointestinal Neoplasms | 2 | 2013 | 76 | 0.450 |
Why?
| | Pancreas | 7 | 2021 | 326 | 0.450 |
Why?
| | Lithotripsy | 6 | 2024 | 46 | 0.450 |
Why?
| | Laparoscopy | 6 | 2020 | 463 | 0.440 |
Why?
| | Suction | 2 | 2017 | 32 | 0.440 |
Why?
| | Female | 96 | 2025 | 75515 | 0.440 |
Why?
| | Catheter Ablation | 5 | 2022 | 313 | 0.430 |
Why?
| | Postoperative Hemorrhage | 3 | 2017 | 89 | 0.420 |
Why?
| | Gallstones | 6 | 1996 | 33 | 0.410 |
Why?
| | Esophagoscopy | 8 | 2022 | 213 | 0.410 |
Why?
| | Postoperative Complications | 11 | 2024 | 2797 | 0.390 |
Why?
| | Propofol | 4 | 2023 | 89 | 0.370 |
Why?
| | Sensitivity and Specificity | 11 | 2019 | 1973 | 0.370 |
Why?
| | Adult | 60 | 2025 | 39177 | 0.370 |
Why?
| | Body Weight | 1 | 2016 | 996 | 0.370 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 4 | 2025 | 348 | 0.360 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2017 | 2526 | 0.360 |
Why?
| | Biopsy | 5 | 2019 | 1081 | 0.360 |
Why?
| | Gastroscopy | 4 | 2014 | 18 | 0.350 |
Why?
| | Precancerous Conditions | 4 | 2017 | 166 | 0.350 |
Why?
| | Colorectal Neoplasms | 5 | 2022 | 802 | 0.340 |
Why?
| | Aged, 80 and over | 23 | 2025 | 7856 | 0.340 |
Why?
| | Quality Indicators, Health Care | 5 | 2018 | 308 | 0.340 |
Why?
| | Bile Ducts | 5 | 2014 | 66 | 0.340 |
Why?
| | Duodenal Neoplasms | 2 | 2023 | 24 | 0.320 |
Why?
| | Ampulla of Vater | 3 | 2023 | 34 | 0.320 |
Why?
| | Pancreatic Cyst | 3 | 2018 | 48 | 0.320 |
Why?
| | Cytodiagnosis | 2 | 2020 | 32 | 0.320 |
Why?
| | Pancreatitis, Acute Necrotizing | 3 | 2023 | 14 | 0.310 |
Why?
| | Insufflation | 1 | 2009 | 13 | 0.310 |
Why?
| | Constriction, Pathologic | 6 | 2022 | 238 | 0.310 |
Why?
| | In Situ Hybridization, Fluorescence | 2 | 2020 | 310 | 0.290 |
Why?
| | Common Bile Duct Neoplasms | 2 | 2023 | 23 | 0.290 |
Why?
| | Esophagogastric Junction | 3 | 2019 | 52 | 0.290 |
Why?
| | Cholecystectomy, Laparoscopic | 6 | 2008 | 52 | 0.290 |
Why?
| | Retrospective Studies | 35 | 2025 | 16273 | 0.280 |
Why?
| | Calculi | 3 | 2019 | 16 | 0.270 |
Why?
| | Carbon Dioxide | 1 | 2009 | 243 | 0.270 |
Why?
| | Decompression, Surgical | 2 | 2023 | 113 | 0.260 |
Why?
| | Gastrointestinal Stromal Tumors | 3 | 2015 | 38 | 0.250 |
Why?
| | Prosthesis Implantation | 3 | 2019 | 157 | 0.250 |
Why?
| | Sphincterotomy, Endoscopic | 6 | 2019 | 29 | 0.250 |
Why?
| | Quality of Life | 11 | 2024 | 2999 | 0.250 |
Why?
| | Pain, Postoperative | 1 | 2009 | 309 | 0.250 |
Why?
| | Endoscopes, Gastrointestinal | 1 | 2006 | 13 | 0.240 |
Why?
| | Thoracoscopy | 1 | 2006 | 58 | 0.240 |
Why?
| | Pancreatectomy | 2 | 2021 | 262 | 0.240 |
Why?
| | Body Mass Index | 7 | 2019 | 2382 | 0.240 |
Why?
| | Follow-Up Studies | 16 | 2015 | 5200 | 0.240 |
Why?
| | Neoplasm Recurrence, Local | 4 | 2023 | 1073 | 0.230 |
Why?
| | Neuroendocrine Tumors | 2 | 2018 | 109 | 0.230 |
Why?
| | Mental Recall | 1 | 2006 | 209 | 0.220 |
Why?
| | Early Detection of Cancer | 5 | 2022 | 441 | 0.220 |
Why?
| | Esophageal Sphincter, Lower | 2 | 2015 | 14 | 0.220 |
Why?
| | Polyvinyls | 1 | 2004 | 21 | 0.220 |
Why?
| | Magnets | 2 | 2015 | 20 | 0.210 |
Why?
| | Societies, Medical | 3 | 2018 | 855 | 0.210 |
Why?
| | Plastics | 3 | 2022 | 50 | 0.210 |
Why?
| | Gastric Bypass | 2 | 2017 | 119 | 0.200 |
Why?
| | Periodicals as Topic | 1 | 2006 | 217 | 0.200 |
Why?
| | Ablation Techniques | 3 | 2017 | 34 | 0.200 |
Why?
| | Common Bile Duct | 3 | 2009 | 14 | 0.190 |
Why?
| | Internet | 2 | 2009 | 690 | 0.190 |
Why?
| | Gastrointestinal Tract | 1 | 2025 | 204 | 0.190 |
Why?
| | Fluoroscopy | 3 | 2019 | 169 | 0.190 |
Why?
| | Patient Satisfaction | 1 | 2006 | 695 | 0.190 |
Why?
| | Prostheses and Implants | 3 | 2013 | 144 | 0.180 |
Why?
| | Pneumonia, Aspiration | 2 | 2019 | 17 | 0.180 |
Why?
| | Carcinoma, Pancreatic Ductal | 3 | 2017 | 277 | 0.170 |
Why?
| | Deglutition Disorders | 3 | 2019 | 148 | 0.170 |
Why?
| | Risk Factors | 14 | 2025 | 10438 | 0.170 |
Why?
| | Carcinoembryonic Antigen | 3 | 2018 | 38 | 0.170 |
Why?
| | Intestinal Perforation | 2 | 2018 | 45 | 0.170 |
Why?
| | Prosthesis Design | 3 | 2019 | 335 | 0.170 |
Why?
| | Varicose Veins | 1 | 2020 | 16 | 0.170 |
Why?
| | Logistic Models | 7 | 2024 | 2086 | 0.170 |
Why?
| | Double-Blind Method | 7 | 2018 | 1983 | 0.170 |
Why?
| | Esophageal and Gastric Varices | 1 | 2020 | 35 | 0.160 |
Why?
| | Biliary Tract Diseases | 4 | 2014 | 33 | 0.160 |
Why?
| | Anesthesia | 1 | 2023 | 248 | 0.160 |
Why?
| | Neoplasm Staging | 5 | 2017 | 1398 | 0.160 |
Why?
| | Cell-Free System | 1 | 2019 | 55 | 0.160 |
Why?
| | Equipment Design | 6 | 2020 | 525 | 0.160 |
Why?
| | Deep Sedation | 2 | 2010 | 17 | 0.160 |
Why?
| | Abdominal Pain | 3 | 2019 | 145 | 0.160 |
Why?
| | Fiducial Markers | 1 | 2019 | 9 | 0.150 |
Why?
| | Urinary Calculi | 1 | 2019 | 10 | 0.150 |
Why?
| | Radiotherapy, Image-Guided | 1 | 2019 | 37 | 0.150 |
Why?
| | Watchful Waiting | 3 | 2019 | 84 | 0.150 |
Why?
| | Needles | 1 | 2019 | 63 | 0.150 |
Why?
| | Academic Medical Centers | 3 | 2023 | 528 | 0.140 |
Why?
| | Practice Guidelines as Topic | 2 | 2018 | 1597 | 0.140 |
Why?
| | Infection Control | 1 | 2020 | 167 | 0.140 |
Why?
| | Esophageal Stenosis | 1 | 2019 | 55 | 0.140 |
Why?
| | Metals | 4 | 2023 | 140 | 0.140 |
Why?
| | Administration, Rectal | 3 | 2024 | 13 | 0.140 |
Why?
| | Abdomen | 2 | 2016 | 136 | 0.140 |
Why?
| | Cystadenoma, Serous | 1 | 2018 | 18 | 0.140 |
Why?
| | Reproducibility of Results | 7 | 2020 | 3348 | 0.140 |
Why?
| | Aneurysm, False | 1 | 2018 | 45 | 0.140 |
Why?
| | Obesity Management | 1 | 2017 | 8 | 0.140 |
Why?
| | Delayed Diagnosis | 1 | 2018 | 93 | 0.140 |
Why?
| | Cystadenoma, Mucinous | 2 | 2015 | 10 | 0.140 |
Why?
| | Cystadenocarcinoma, Mucinous | 2 | 2015 | 11 | 0.140 |
Why?
| | Suture Techniques | 3 | 2017 | 128 | 0.130 |
Why?
| | Conscious Sedation | 2 | 2023 | 94 | 0.130 |
Why?
| | Calcinosis | 1 | 2019 | 238 | 0.130 |
Why?
| | Liver Neoplasms | 1 | 2023 | 740 | 0.130 |
Why?
| | Pancreaticoduodenectomy | 2 | 2016 | 129 | 0.130 |
Why?
| | Simulation Training | 1 | 2019 | 127 | 0.130 |
Why?
| | Diagnostic Tests, Routine | 1 | 2018 | 110 | 0.130 |
Why?
| | Insurance, Health, Reimbursement | 1 | 2017 | 96 | 0.130 |
Why?
| | Diet Therapy | 1 | 2016 | 37 | 0.130 |
Why?
| | Metaplasia | 4 | 2022 | 58 | 0.130 |
Why?
| | Education, Medical, Graduate | 2 | 2019 | 522 | 0.130 |
Why?
| | Immunoassay | 1 | 2017 | 113 | 0.130 |
Why?
| | Polymerase Chain Reaction | 1 | 2019 | 1056 | 0.120 |
Why?
| | Stomach | 1 | 2016 | 110 | 0.120 |
Why?
| | Respiratory Insufficiency | 2 | 2010 | 326 | 0.120 |
Why?
| | Population Surveillance | 2 | 2017 | 481 | 0.120 |
Why?
| | Neoplasms, Cystic, Mucinous, and Serous | 1 | 2016 | 26 | 0.120 |
Why?
| | Bariatric Medicine | 1 | 2015 | 2 | 0.120 |
Why?
| | Single-Blind Method | 5 | 2019 | 288 | 0.120 |
Why?
| | Young Adult | 11 | 2025 | 13673 | 0.120 |
Why?
| | Intubation, Gastrointestinal | 1 | 1996 | 77 | 0.120 |
Why?
| | Referral and Consultation | 3 | 2019 | 798 | 0.120 |
Why?
| | Colon, Ascending | 1 | 2015 | 2 | 0.120 |
Why?
| | Intestinal Mucosa | 3 | 2017 | 631 | 0.120 |
Why?
| | Life Style | 2 | 2018 | 482 | 0.120 |
Why?
| | Dissection | 1 | 2015 | 55 | 0.110 |
Why?
| | Dogs | 1 | 2016 | 427 | 0.110 |
Why?
| | Documentation | 1 | 2017 | 199 | 0.110 |
Why?
| | Fellowships and Scholarships | 1 | 2019 | 319 | 0.110 |
Why?
| | Neoplasms, Multiple Primary | 1 | 2015 | 59 | 0.110 |
Why?
| | Cholecystectomy | 4 | 2009 | 58 | 0.110 |
Why?
| | Time Factors | 9 | 2025 | 6956 | 0.110 |
Why?
| | Hospitalization | 1 | 2025 | 2255 | 0.110 |
Why?
| | Pilot Projects | 2 | 2013 | 1820 | 0.110 |
Why?
| | Peristalsis | 2 | 1991 | 30 | 0.110 |
Why?
| | Leiomyoma | 1 | 2015 | 56 | 0.110 |
Why?
| | Proton Pump Inhibitors | 3 | 2020 | 108 | 0.110 |
Why?
| | Aptitude | 1 | 2014 | 37 | 0.110 |
Why?
| | Colorectal Surgery | 1 | 2014 | 30 | 0.110 |
Why?
| | Multivariate Analysis | 4 | 2021 | 1490 | 0.110 |
Why?
| | Ulcer | 1 | 2014 | 34 | 0.110 |
Why?
| | Incidence | 6 | 2025 | 2794 | 0.100 |
Why?
| | Colectomy | 1 | 2014 | 107 | 0.100 |
Why?
| | Liver Cirrhosis | 2 | 2020 | 282 | 0.100 |
Why?
| | Biomarkers, Tumor | 3 | 2017 | 1251 | 0.100 |
Why?
| | Predictive Value of Tests | 6 | 2016 | 2070 | 0.100 |
Why?
| | Anastomosis, Roux-en-Y | 1 | 2013 | 26 | 0.100 |
Why?
| | Cholangiopancreatography, Magnetic Resonance | 1 | 2013 | 24 | 0.100 |
Why?
| | Patient Safety | 1 | 2016 | 335 | 0.100 |
Why?
| | Multidetector Computed Tomography | 1 | 2013 | 40 | 0.100 |
Why?
| | Hemorrhage | 1 | 2018 | 760 | 0.100 |
Why?
| | Community Health Services | 1 | 2014 | 233 | 0.100 |
Why?
| | Bile Duct Diseases | 1 | 2012 | 12 | 0.100 |
Why?
| | Ultrasonography, Interventional | 2 | 2015 | 155 | 0.090 |
Why?
| | Contrast Media | 1 | 1995 | 470 | 0.090 |
Why?
| | Recurrence | 4 | 2020 | 1110 | 0.090 |
Why?
| | Cholecystitis | 1 | 1992 | 23 | 0.090 |
Why?
| | Risk Assessment | 8 | 2016 | 3490 | 0.090 |
Why?
| | Exercise Therapy | 1 | 2016 | 447 | 0.090 |
Why?
| | Health Care Costs | 1 | 2015 | 424 | 0.090 |
Why?
| | Cholestasis, Extrahepatic | 1 | 1991 | 3 | 0.090 |
Why?
| | Diverticulum | 1 | 1991 | 12 | 0.090 |
Why?
| | Lymph Nodes | 2 | 2012 | 502 | 0.090 |
Why?
| | Duodenal Diseases | 1 | 1991 | 8 | 0.090 |
Why?
| | Digestive System Diseases | 1 | 2011 | 26 | 0.090 |
Why?
| | Diagnosis, Differential | 6 | 2015 | 1498 | 0.090 |
Why?
| | Esophageal Diseases | 1 | 1991 | 28 | 0.090 |
Why?
| | Sensation | 1 | 1991 | 56 | 0.090 |
Why?
| | Chest Pain | 1 | 1991 | 96 | 0.080 |
Why?
| | Hypotension | 1 | 2011 | 122 | 0.080 |
Why?
| | Deglutition | 1 | 1991 | 71 | 0.080 |
Why?
| | Severity of Illness Index | 1 | 2019 | 2892 | 0.080 |
Why?
| | Patient Compliance | 1 | 2015 | 610 | 0.080 |
Why?
| | Hepatic Duct, Common | 1 | 2010 | 5 | 0.080 |
Why?
| | Proteomics | 1 | 2017 | 1134 | 0.080 |
Why?
| | Image Enhancement | 1 | 2011 | 191 | 0.080 |
Why?
| | Colonoscopes | 1 | 2009 | 5 | 0.080 |
Why?
| | Muscle, Smooth | 1 | 1991 | 154 | 0.080 |
Why?
| | Bile | 1 | 2009 | 25 | 0.080 |
Why?
| | Cholecystostomy | 1 | 1989 | 3 | 0.080 |
Why?
| | United States | 10 | 2018 | 15220 | 0.080 |
Why?
| | Disease Progression | 5 | 2017 | 2793 | 0.080 |
Why?
| | Length of Stay | 5 | 2025 | 1254 | 0.080 |
Why?
| | Odds Ratio | 4 | 2016 | 1052 | 0.080 |
Why?
| | Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2010 | 77 | 0.080 |
Why?
| | Sleep Apnea Syndromes | 1 | 2010 | 90 | 0.080 |
Why?
| | Loss of Heterozygosity | 1 | 2009 | 51 | 0.070 |
Why?
| | Abdominal Neoplasms | 1 | 2009 | 47 | 0.070 |
Why?
| | Equipment Safety | 2 | 2009 | 37 | 0.070 |
Why?
| | Tumor Burden | 3 | 2015 | 312 | 0.070 |
Why?
| | Intestinal Obstruction | 1 | 2009 | 52 | 0.070 |
Why?
| | DNA, Neoplasm | 1 | 2009 | 158 | 0.070 |
Why?
| | Cholangiography | 1 | 2008 | 9 | 0.070 |
Why?
| | Mutation | 1 | 2019 | 4013 | 0.070 |
Why?
| | Anesthetics | 1 | 2009 | 98 | 0.070 |
Why?
| | Choledocholithiasis | 1 | 2008 | 19 | 0.070 |
Why?
| | Adolescent | 8 | 2025 | 22007 | 0.070 |
Why?
| | Quality Assurance, Health Care | 1 | 2010 | 331 | 0.070 |
Why?
| | Video Recording | 3 | 2014 | 190 | 0.070 |
Why?
| | Ultrasonography | 4 | 1996 | 755 | 0.070 |
Why?
| | Feeding Behavior | 1 | 2013 | 681 | 0.070 |
Why?
| | Health Services Research | 1 | 2010 | 406 | 0.070 |
Why?
| | Positron-Emission Tomography | 1 | 2008 | 310 | 0.060 |
Why?
| | Biopsy, Needle | 2 | 2004 | 187 | 0.060 |
Why?
| | Acute Disease | 4 | 2008 | 1008 | 0.060 |
Why?
| | Registries | 1 | 2015 | 2135 | 0.060 |
Why?
| | Hyperplasia | 2 | 2019 | 176 | 0.060 |
Why?
| | Pleural Diseases | 1 | 2006 | 23 | 0.060 |
Why?
| | Pancreatic Fistula | 1 | 2006 | 33 | 0.060 |
Why?
| | Research Design | 2 | 2016 | 1143 | 0.060 |
Why?
| | Prognosis | 5 | 2017 | 4073 | 0.060 |
Why?
| | Delphi Technique | 2 | 2017 | 308 | 0.060 |
Why?
| | Pain | 2 | 2022 | 781 | 0.060 |
Why?
| | Autonomic Nerve Block | 1 | 2024 | 10 | 0.060 |
Why?
| | Celiac Plexus | 1 | 2024 | 6 | 0.060 |
Why?
| | Hospital Units | 1 | 2004 | 32 | 0.060 |
Why?
| | Health Care Surveys | 3 | 2014 | 565 | 0.050 |
Why?
| | Cohort Studies | 5 | 2020 | 5799 | 0.050 |
Why?
| | Cyst Fluid | 2 | 2018 | 21 | 0.050 |
Why?
| | Ambulatory Surgical Procedures | 1 | 2025 | 74 | 0.050 |
Why?
| | Hypoxia | 1 | 2011 | 1164 | 0.050 |
Why?
| | Tertiary Care Centers | 2 | 2016 | 178 | 0.050 |
Why?
| | Surveys and Questionnaires | 4 | 2015 | 5929 | 0.050 |
Why?
| | Diphenhydramine | 1 | 2023 | 36 | 0.050 |
Why?
| | Efficiency, Organizational | 1 | 2004 | 139 | 0.050 |
Why?
| | Midazolam | 1 | 2023 | 72 | 0.050 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2008 | 642 | 0.050 |
Why?
| | Missouri | 2 | 2014 | 60 | 0.050 |
Why?
| | Observer Variation | 2 | 2014 | 355 | 0.050 |
Why?
| | Disposable Equipment | 2 | 2009 | 21 | 0.050 |
Why?
| | Electrocoagulation | 1 | 2023 | 35 | 0.050 |
Why?
| | Fentanyl | 1 | 2023 | 120 | 0.050 |
Why?
| | Pain Measurement | 1 | 2024 | 554 | 0.050 |
Why?
| | Necrosis | 1 | 2023 | 249 | 0.050 |
Why?
| | Animals | 3 | 2020 | 37657 | 0.050 |
Why?
| | Esophagitis, Peptic | 1 | 2002 | 17 | 0.050 |
Why?
| | Guidelines as Topic | 2 | 2015 | 273 | 0.050 |
Why?
| | Mass Screening | 1 | 2010 | 1310 | 0.040 |
Why?
| | Hypnotics and Sedatives | 1 | 2023 | 214 | 0.040 |
Why?
| | Cholestasis, Intrahepatic | 1 | 2001 | 29 | 0.040 |
Why?
| | Neoplasms | 1 | 2016 | 2741 | 0.040 |
Why?
| | Endoscopes | 2 | 1998 | 17 | 0.040 |
Why?
| | Bile Ducts, Intrahepatic | 1 | 2001 | 58 | 0.040 |
Why?
| | Tomography, X-Ray Computed | 3 | 2006 | 2746 | 0.040 |
Why?
| | Lumbar Vertebrae | 1 | 2023 | 250 | 0.040 |
Why?
| | Hyperthermia, Induced | 1 | 2002 | 120 | 0.040 |
Why?
| | Silicones | 1 | 2020 | 26 | 0.040 |
Why?
| | Portasystemic Shunt, Transjugular Intrahepatic | 1 | 2000 | 38 | 0.040 |
Why?
| | Hemostatic Techniques | 1 | 2000 | 50 | 0.040 |
Why?
| | Combined Modality Therapy | 2 | 2016 | 1243 | 0.040 |
Why?
| | Los Angeles | 1 | 2020 | 75 | 0.040 |
Why?
| | Fundoplication | 1 | 2020 | 56 | 0.040 |
Why?
| | Contraindications | 2 | 2017 | 85 | 0.040 |
Why?
| | Technology Assessment, Biomedical | 5 | 1998 | 40 | 0.040 |
Why?
| | Feasibility Studies | 2 | 2018 | 1018 | 0.040 |
Why?
| | Equivalence Trials as Topic | 1 | 2019 | 12 | 0.040 |
Why?
| | Microscopy, Confocal | 1 | 2020 | 324 | 0.040 |
Why?
| | Clinical Trials as Topic | 2 | 2015 | 1052 | 0.040 |
Why?
| | Adenocarcinoma, Mucinous | 2 | 2009 | 76 | 0.040 |
Why?
| | Probability | 2 | 2009 | 309 | 0.040 |
Why?
| | Electrosurgery | 1 | 1998 | 44 | 0.030 |
Why?
| | Electrodes | 1 | 1998 | 114 | 0.030 |
Why?
| | Radiology | 1 | 2000 | 170 | 0.030 |
Why?
| | Resuscitation | 1 | 2000 | 278 | 0.030 |
Why?
| | Swine | 1 | 2020 | 806 | 0.030 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2006 | 1396 | 0.030 |
Why?
| | Reference Standards | 1 | 2018 | 186 | 0.030 |
Why?
| | General Surgery | 1 | 2000 | 199 | 0.030 |
Why?
| | Surgical Instruments | 1 | 2018 | 50 | 0.030 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2018 | 95 | 0.030 |
Why?
| | Practice Patterns, Physicians' | 3 | 2014 | 1336 | 0.030 |
Why?
| | Statistics, Nonparametric | 2 | 2008 | 434 | 0.030 |
Why?
| | Granulation Tissue | 1 | 2016 | 7 | 0.030 |
Why?
| | Manometry | 2 | 2001 | 97 | 0.030 |
Why?
| | Minimally Invasive Surgical Procedures | 2 | 2008 | 179 | 0.030 |
Why?
| | Organizational Policy | 1 | 2017 | 83 | 0.030 |
Why?
| | Surgery, Computer-Assisted | 1 | 2017 | 78 | 0.030 |
Why?
| | Neoplasm Seeding | 1 | 1996 | 7 | 0.030 |
Why?
| | Cystic Duct | 1 | 1996 | 3 | 0.030 |
Why?
| | Gastric Fistula | 1 | 1996 | 9 | 0.030 |
Why?
| | Tissue Banks | 1 | 2016 | 17 | 0.030 |
Why?
| | Cutaneous Fistula | 1 | 1996 | 14 | 0.030 |
Why?
| | Patient Admission | 1 | 2018 | 203 | 0.030 |
Why?
| | Fasciitis, Necrotizing | 1 | 1996 | 16 | 0.030 |
Why?
| | Intestinal Fistula | 1 | 1996 | 17 | 0.030 |
Why?
| | Foreign-Body Migration | 1 | 1996 | 32 | 0.030 |
Why?
| | Analgesics, Opioid | 1 | 2024 | 1116 | 0.030 |
Why?
| | Digestive System | 1 | 1995 | 28 | 0.030 |
Why?
| | Iopamidol | 1 | 1995 | 12 | 0.030 |
Why?
| | Diatrizoate Meglumine | 1 | 1995 | 6 | 0.030 |
Why?
| | Prevalence | 2 | 2015 | 2772 | 0.030 |
Why?
| | Image-Guided Biopsy | 1 | 2015 | 39 | 0.030 |
Why?
| | Decision Trees | 1 | 2015 | 82 | 0.030 |
Why?
| | Survival Rate | 1 | 2000 | 1970 | 0.030 |
Why?
| | Weight Reduction Programs | 1 | 2017 | 117 | 0.030 |
Why?
| | Quality-Adjusted Life Years | 1 | 2015 | 113 | 0.030 |
Why?
| | Longitudinal Studies | 2 | 2015 | 2902 | 0.030 |
Why?
| | Osmolar Concentration | 1 | 1995 | 167 | 0.030 |
Why?
| | Peritonitis | 1 | 1996 | 87 | 0.030 |
Why?
| | Markov Chains | 1 | 2015 | 126 | 0.030 |
Why?
| | Netherlands | 1 | 2015 | 87 | 0.030 |
Why?
| | Patient Care Team | 1 | 2000 | 664 | 0.030 |
Why?
| | Costs and Cost Analysis | 1 | 2015 | 222 | 0.030 |
Why?
| | Child, Preschool | 2 | 2022 | 11457 | 0.030 |
Why?
| | Patient Reported Outcome Measures | 1 | 2019 | 433 | 0.030 |
Why?
| | Behavior Therapy | 1 | 2017 | 280 | 0.030 |
Why?
| | Incidental Findings | 1 | 2015 | 80 | 0.030 |
Why?
| | Clinical Protocols | 1 | 2016 | 273 | 0.030 |
Why?
| | Confidence Intervals | 1 | 2015 | 329 | 0.030 |
Why?
| | Magnetic Resonance Imaging | 1 | 2006 | 3709 | 0.030 |
Why?
| | Outpatient Clinics, Hospital | 1 | 2014 | 82 | 0.030 |
Why?
| | Electronic Health Records | 1 | 2022 | 1122 | 0.030 |
Why?
| | Consensus | 1 | 2017 | 704 | 0.030 |
Why?
| | Advisory Committees | 1 | 2015 | 220 | 0.030 |
Why?
| | Lipids | 1 | 2018 | 689 | 0.030 |
Why?
| | Enteral Nutrition | 1 | 1995 | 202 | 0.030 |
Why?
| | Monitoring, Physiologic | 1 | 1995 | 285 | 0.030 |
Why?
| | Health Status Indicators | 1 | 2014 | 163 | 0.030 |
Why?
| | Patient Participation | 1 | 2017 | 432 | 0.030 |
Why?
| | Medicaid | 1 | 2017 | 451 | 0.030 |
Why?
| | ROC Curve | 1 | 2015 | 586 | 0.030 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1306 | 0.020 |
Why?
| | Patient Selection | 1 | 2017 | 688 | 0.020 |
Why?
| | Program Evaluation | 1 | 2017 | 928 | 0.020 |
Why?
| | Cost-Benefit Analysis | 1 | 2015 | 618 | 0.020 |
Why?
| | Sphincter of Oddi | 1 | 2012 | 5 | 0.020 |
Why?
| | Colic | 1 | 1992 | 8 | 0.020 |
Why?
| | Evidence-Based Medicine | 1 | 2017 | 750 | 0.020 |
Why?
| | Mediastinum | 1 | 2012 | 22 | 0.020 |
Why?
| | Radio Waves | 2 | 2003 | 28 | 0.020 |
Why?
| | Esophagitis | 1 | 2013 | 68 | 0.020 |
Why?
| | Adenoma, Villous | 1 | 2012 | 2 | 0.020 |
Why?
| | Mucous Membrane | 1 | 2013 | 125 | 0.020 |
Why?
| | Intensive Care Units | 1 | 2018 | 868 | 0.020 |
Why?
| | Medicare | 1 | 2017 | 799 | 0.020 |
Why?
| | Blood Pressure | 1 | 2018 | 1748 | 0.020 |
Why?
| | Anesthetics, Intravenous | 1 | 2011 | 64 | 0.020 |
Why?
| | Decision Support Techniques | 1 | 2015 | 431 | 0.020 |
Why?
| | Palliative Care | 1 | 2019 | 817 | 0.020 |
Why?
| | Injections, Intravenous | 1 | 2011 | 202 | 0.020 |
Why?
| | Heartburn | 2 | 2001 | 12 | 0.020 |
Why?
| | Edema | 1 | 2011 | 131 | 0.020 |
Why?
| | Body Height | 1 | 1991 | 196 | 0.020 |
Why?
| | Polyethylene | 1 | 2010 | 17 | 0.020 |
Why?
| | Gastroscopes | 1 | 2010 | 3 | 0.020 |
Why?
| | Esophageal pH Monitoring | 1 | 2010 | 23 | 0.020 |
Why?
| | Epithelium | 1 | 2011 | 316 | 0.020 |
Why?
| | Duodenoscopy | 1 | 2009 | 7 | 0.020 |
Why?
| | Preoperative Care | 1 | 1992 | 371 | 0.020 |
Why?
| | Methods | 1 | 1989 | 68 | 0.020 |
Why?
| | Punctures | 1 | 1989 | 39 | 0.020 |
Why?
| | Radiography | 1 | 1992 | 844 | 0.020 |
Why?
| | Diet | 1 | 2017 | 1282 | 0.020 |
Why?
| | Hydrogen-Ion Concentration | 2 | 2001 | 556 | 0.020 |
Why?
| | Injections | 1 | 2010 | 191 | 0.020 |
Why?
| | Reference Values | 1 | 1991 | 805 | 0.020 |
Why?
| | Psychiatric Status Rating Scales | 1 | 1991 | 561 | 0.020 |
Why?
| | Adenocarcinoma, Papillary | 1 | 2009 | 11 | 0.020 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2009 | 67 | 0.020 |
Why?
| | Kaplan-Meier Estimate | 1 | 2011 | 908 | 0.020 |
Why?
| | Light | 1 | 2011 | 394 | 0.020 |
Why?
| | Nervous System Diseases | 1 | 1991 | 275 | 0.020 |
Why?
| | Age Distribution | 1 | 2009 | 395 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 379 | 0.020 |
Why?
| | ras Proteins | 1 | 2009 | 148 | 0.020 |
Why?
| | Muscle Contraction | 1 | 1991 | 435 | 0.020 |
Why?
| | Radiopharmaceuticals | 1 | 2008 | 188 | 0.020 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2008 | 147 | 0.020 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2009 | 263 | 0.020 |
Why?
| | Specimen Handling | 1 | 2009 | 182 | 0.020 |
Why?
| | Age Factors | 1 | 2015 | 3292 | 0.020 |
Why?
| | Intraoperative Complications | 1 | 2008 | 148 | 0.020 |
Why?
| | Decision Making | 1 | 2014 | 961 | 0.020 |
Why?
| | Early Diagnosis | 1 | 2008 | 244 | 0.020 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2009 | 333 | 0.020 |
Why?
| | Safety Management | 1 | 2007 | 126 | 0.020 |
Why?
| | Survival Analysis | 1 | 2009 | 1319 | 0.020 |
Why?
| | Exercise | 1 | 2017 | 2103 | 0.010 |
Why?
| | Thoracic Surgery | 1 | 2008 | 141 | 0.010 |
Why?
| | Analysis of Variance | 1 | 2008 | 1320 | 0.010 |
Why?
| | Proto-Oncogene Proteins | 1 | 2009 | 623 | 0.010 |
Why?
| | Cross-Sectional Studies | 2 | 2008 | 5636 | 0.010 |
Why?
| | Immunohistochemistry | 1 | 2009 | 1737 | 0.010 |
Why?
| | Comorbidity | 1 | 2009 | 1662 | 0.010 |
Why?
| | Personnel Staffing and Scheduling | 1 | 2004 | 96 | 0.010 |
Why?
| | Child | 2 | 2018 | 22308 | 0.010 |
Why?
| | Infant | 1 | 2018 | 9818 | 0.010 |
Why?
| | Sex Factors | 1 | 2009 | 2058 | 0.010 |
Why?
| | False Negative Reactions | 1 | 2002 | 61 | 0.010 |
Why?
| | Gastric Acidity Determination | 1 | 2002 | 6 | 0.010 |
Why?
| | Reoperation | 2 | 1996 | 588 | 0.010 |
Why?
| | Attitude of Health Personnel | 1 | 2009 | 1171 | 0.010 |
Why?
| | Energy Transfer | 1 | 2001 | 48 | 0.010 |
Why?
| | Cholangiocarcinoma | 1 | 2001 | 94 | 0.010 |
Why?
| | Computer Simulation | 1 | 2004 | 1015 | 0.010 |
Why?
| | Equipment Failure | 1 | 1998 | 111 | 0.010 |
Why?
| | Safety | 1 | 1998 | 356 | 0.010 |
Why?
| | Radiology, Interventional | 1 | 1996 | 32 | 0.010 |
Why?
| | Blood Pressure Determination | 1 | 1995 | 145 | 0.010 |
Why?
| | Oximetry | 1 | 1995 | 127 | 0.010 |
Why?
| | Technetium Tc 99m Disofenin | 1 | 1992 | 3 | 0.010 |
Why?
| | Sincalide | 1 | 1992 | 5 | 0.010 |
Why?
| | Organotechnetium Compounds | 1 | 1992 | 11 | 0.010 |
Why?
| | Imino Acids | 1 | 1992 | 6 | 0.010 |
Why?
| | Gallbladder | 1 | 1992 | 15 | 0.010 |
Why?
| | Electrocardiography | 1 | 1995 | 618 | 0.010 |
Why?
| | Radionuclide Imaging | 1 | 1992 | 116 | 0.010 |
Why?
| | Aniline Compounds | 1 | 1992 | 109 | 0.010 |
Why?
| | Glycine | 1 | 1992 | 182 | 0.010 |
Why?
| | Chronic Disease | 1 | 1995 | 1816 | 0.000 |
Why?
| | Pregnancy | 1 | 2001 | 7070 | 0.000 |
Why?
|
|
Edmundowicz's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|